Norcantharidin: A potential antiangiogenic agent for gallbladder cancers in vitro and in vivo

Author：          

Publisher： Spandidos Publications

ISSN： 1019-6439

Source： International Journal of Oncology, Vol.40, Iss.5, 2012-01, pp. : 1501-1514

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Norcantharidin enhances TIMP2 antivasculogenic mimicry activity for human gallbladder cancers through downregulating MMP2 and MT1MMP

By  

International Journal of Oncology, Vol. 46, Iss. 2, 2015-01 ,pp. : 627-640

Spandidos Publications

Access to resources Recommend Favorite

Study of in vitro and in vivo effects of the piperidine nitroxide Tempol-a potential new therapeutic agent for gliomas

By Gariboldi M.B.   Ravizza R.   Petterino C.   Castagnaro M.   Finocchiaro G.   Monti E.  

European Journal of Cancer, Vol. 39, Iss. 6, 2003-04 ,pp. : 829-837

Elsevier

Access to resources Recommend Favorite

Studies on the antiangiogenic effect of Marsdenia tenacissima extract in vitro and in vivo

By            

Oncology Letters, Vol. 5, Iss. 3, 2013-01 ,pp. : 917-922

Spandidos Publications

Access to resources Recommend Favorite

Ramucirumab: a novel antiangiogenic agent

By Wadhwa Roopma   Taketa Takashi   Sudo Kazuki   Blum-Murphy Mariela   Ajani Jaffer A  

Future Oncology, Vol. 9, Iss. 6, 2013-06 ,pp. : 789-795

Future Medicine

Access to resources Recommend Favorite

Fascaplysin, a selective CDK4 inhibitor, exhibit anti-angiogenic activity in vitro and in vivo

By Lin Jing   Yan Xiao-Jun   Chen Hai-Min  

Cancer Chemotherapy and Pharmacology, Vol. 59, Iss. 4, 2007-03 ,pp. : 439-445

Springer Publishing Company

Access to resources Recommend Favorite